 | • レポートコード：MRC308GR09539 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の急性骨髄性白血病バイオマーカー検出の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の急性骨髄性白血病バイオマーカー検出市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 急性骨髄性白血病バイオマーカー検出の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
急性骨髄性白血病バイオマーカー検出市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・次世代シーケンシング技術、PCR検出技術
用途別セグメント
・病院、研究機関、その他
主要な市場プレーヤー
・Abbott Laboratories、Bio-Rad Laboratories, Inc.、Genmark Saghlk Orinleri、Laboratory Corporation of America Holdings、Danaher、Medaysis Company、NeoGenomics Laboratories、QIAGEN N.V.、Thermo Fisher Scientific, Inc.、GeneTex
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、急性骨髄性白血病バイオマーカー検出製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な急性骨髄性白血病バイオマーカー検出メーカーの企業概要、2019年～2022年までの急性骨髄性白血病バイオマーカー検出の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な急性骨髄性白血病バイオマーカー検出メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別急性骨髄性白血病バイオマーカー検出の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの急性骨髄性白血病バイオマーカー検出の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での急性骨髄性白血病バイオマーカー検出市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および急性骨髄性白血病バイオマーカー検出の産業チェーンを掲載しています。
・第14、15章では、急性骨髄性白血病バイオマーカー検出の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 急性骨髄性白血病バイオマーカー検出の概要
– 種類別分析（2018年vs2022年vs2029年）：次世代シーケンシング技術、PCR検出技術
– 用途別分析（2018年vs2022年vs2029年）：病院、研究機関、その他
– 世界の急性骨髄性白血病バイオマーカー検出市場規模・予測
– 世界の急性骨髄性白血病バイオマーカー検出生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Abbott Laboratories、Bio-Rad Laboratories, Inc.、Genmark Saghlk Orinleri、Laboratory Corporation of America Holdings、Danaher、Medaysis Company、NeoGenomics Laboratories、QIAGEN N.V.、Thermo Fisher Scientific, Inc.、GeneTex
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：次世代シーケンシング技術、PCR検出技術
・用途別分析2018年-2029年：病院、研究機関、その他
・急性骨髄性白血病バイオマーカー検出の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・急性骨髄性白血病バイオマーカー検出のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・急性骨髄性白血病バイオマーカー検出のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・急性骨髄性白血病バイオマーカー検出の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・急性骨髄性白血病バイオマーカー検出の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Acute Myeloid Leukemia Biomarker Detection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Next Generation Sequencing Technology
1.3.3 PCR Detection Technology
1.4 Market Analysis by Application
1.4.1 Overview: Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Research Institutions
1.4.4 Other
1.5 Global Acute Myeloid Leukemia Biomarker Detection Market Size & Forecast
1.5.1 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity (2018-2029)
1.5.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
2.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments/Updates
2.2 Bio-Rad Laboratories, Inc.
2.2.1 Bio-Rad Laboratories, Inc. Details
2.2.2 Bio-Rad Laboratories, Inc. Major Business
2.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
2.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
2.3 Genmark Saghlk Orinleri
2.3.1 Genmark Saghlk Orinleri Details
2.3.2 Genmark Saghlk Orinleri Major Business
2.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
2.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genmark Saghlk Orinleri Recent Developments/Updates
2.4 Laboratory Corporation of America Holdings
2.4.1 Laboratory Corporation of America Holdings Details
2.4.2 Laboratory Corporation of America Holdings Major Business
2.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
2.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
2.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Danaher Recent Developments/Updates
2.6 Medaysis Company
2.6.1 Medaysis Company Details
2.6.2 Medaysis Company Major Business
2.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
2.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Medaysis Company Recent Developments/Updates
2.7 NeoGenomics Laboratories
2.7.1 NeoGenomics Laboratories Details
2.7.2 NeoGenomics Laboratories Major Business
2.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
2.7.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NeoGenomics Laboratories Recent Developments/Updates
2.8 QIAGEN N.V.
2.8.1 QIAGEN N.V. Details
2.8.2 QIAGEN N.V. Major Business
2.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
2.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 QIAGEN N.V. Recent Developments/Updates
2.9 Thermo Fisher Scientific, Inc.
2.9.1 Thermo Fisher Scientific, Inc. Details
2.9.2 Thermo Fisher Scientific, Inc. Major Business
2.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
2.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
2.10 GeneTex
2.10.1 GeneTex Details
2.10.2 GeneTex Major Business
2.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
2.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GeneTex Recent Developments/Updates
3 Competitive Environment: Acute Myeloid Leukemia Biomarker Detection by Manufacturer
3.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Manufacturer (2018-2023)
3.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Acute Myeloid Leukemia Biomarker Detection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Acute Myeloid Leukemia Biomarker Detection Manufacturer Market Share in 2022
3.4.2 Top 6 Acute Myeloid Leukemia Biomarker Detection Manufacturer Market Share in 2022
3.5 Acute Myeloid Leukemia Biomarker Detection Market: Overall Company Footprint Analysis
3.5.1 Acute Myeloid Leukemia Biomarker Detection Market: Region Footprint
3.5.2 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
3.5.3 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region
4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2018-2029)
4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2018-2029)
4.1.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2029)
4.2 North America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029)
4.3 Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029)
4.4 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029)
4.5 South America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029)
4.6 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
5.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type (2018-2029)
5.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
6.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application (2018-2029)
6.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029)
7 North America
7.1 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
7.2 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
7.3 North America Acute Myeloid Leukemia Biomarker Detection Market Size by Country
7.3.1 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2029)
7.3.2 North America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
8.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
8.3 Europe Acute Myeloid Leukemia Biomarker Detection Market Size by Country
8.3.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2029)
8.3.2 Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Market Size by Region
9.3.1 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
10.2 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
10.3 South America Acute Myeloid Leukemia Biomarker Detection Market Size by Country
10.3.1 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2029)
10.3.2 South America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Market Size by Country
11.3.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Acute Myeloid Leukemia Biomarker Detection Market Drivers
12.2 Acute Myeloid Leukemia Biomarker Detection Market Restraints
12.3 Acute Myeloid Leukemia Biomarker Detection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Acute Myeloid Leukemia Biomarker Detection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Acute Myeloid Leukemia Biomarker Detection
13.3 Acute Myeloid Leukemia Biomarker Detection Production Process
13.4 Acute Myeloid Leukemia Biomarker Detection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Acute Myeloid Leukemia Biomarker Detection Typical Distributors
14.3 Acute Myeloid Leukemia Biomarker Detection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 6. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Laboratories Recent Developments/Updates
Table 8. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Bio-Rad Laboratories, Inc. Major Business
Table 10. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 11. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 13. Genmark Saghlk Orinleri Basic Information, Manufacturing Base and Competitors
Table 14. Genmark Saghlk Orinleri Major Business
Table 15. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 16. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genmark Saghlk Orinleri Recent Developments/Updates
Table 18. Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table 19. Laboratory Corporation of America Holdings Major Business
Table 20. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 21. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 23. Danaher Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Major Business
Table 25. Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 26. Danaher Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Danaher Recent Developments/Updates
Table 28. Medaysis Company Basic Information, Manufacturing Base and Competitors
Table 29. Medaysis Company Major Business
Table 30. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 31. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Medaysis Company Recent Developments/Updates
Table 33. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. NeoGenomics Laboratories Major Business
Table 35. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 36. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. NeoGenomics Laboratories Recent Developments/Updates
Table 38. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 39. QIAGEN N.V. Major Business
Table 40. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 41. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. QIAGEN N.V. Recent Developments/Updates
Table 43. Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Scientific, Inc. Major Business
Table 45. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 46. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 48. GeneTex Basic Information, Manufacturing Base and Competitors
Table 49. GeneTex Major Business
Table 50. GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 51. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GeneTex Recent Developments/Updates
Table 53. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Acute Myeloid Leukemia Biomarker Detection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Acute Myeloid Leukemia Biomarker Detection Production Site of Key Manufacturer
Table 58. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
Table 59. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
Table 60. Acute Myeloid Leukemia Biomarker Detection New Market Entrants and Barriers to Market Entry
Table 61. Acute Myeloid Leukemia Biomarker Detection Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Acute Myeloid Leukemia Biomarker Detection Raw Material
Table 121. Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection Raw Materials
Table 122. Acute Myeloid Leukemia Biomarker Detection Typical Distributors
Table 123. Acute Myeloid Leukemia Biomarker Detection Typical Customers
List of Figures
Figure 1. Acute Myeloid Leukemia Biomarker Detection Picture
Figure 2. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Type in 2022
Figure 4. Next Generation Sequencing Technology Examples
Figure 5. PCR Detection Technology Examples
Figure 6. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Research Institutions Examples
Figure 10. Other Examples
Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Acute Myeloid Leukemia Biomarker Detection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Acute Myeloid Leukemia Biomarker Detection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Acute Myeloid Leukemia Biomarker Detection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Acute Myeloid Leukemia Biomarker Detection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Acute Myeloid Leukemia Biomarker Detection Market Drivers
Figure 74. Acute Myeloid Leukemia Biomarker Detection Market Restraints
Figure 75. Acute Myeloid Leukemia Biomarker Detection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Acute Myeloid Leukemia Biomarker Detection in 2022
Figure 78. Manufacturing Process Analysis of Acute Myeloid Leukemia Biomarker Detection
Figure 79. Acute Myeloid Leukemia Biomarker Detection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source